- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
E-Systems buys two archival firms
Changes continue at E-Systems,the parent of PACS developer Advanced Video Products (AVP). TheDallas-based firm has acquired two archival companies and mergedthem into a new subsidiary, EMASS. The new subsidiary will developproducts that will have
Changes continue at E-Systems,the parent of PACS developer Advanced Video Products (AVP). TheDallas-based firm has acquired two archival companies and mergedthem into a new subsidiary, EMASS. The new subsidiary will developproducts that will have applications in medical imaging, accordingto E-Systems.
The acquired companies are Advanced Archival Products (AAP),a Littleton, CO, developer of storage management software forclient-server environments, and Grau Automation, a manufacturerof automated tape libraries, which is located near Stuttgart,Germany. E-Systems also spun off its mass storage operations intothe new subsidiary. E-Systems executive Mitchell Bohn has beenappointed president and COO of EMASS, to be based in Dallas.
E-Systems has been making moves to reposition itself in themedical market. The company let go 13 employees from AVP lastmonth, but at the same time said it remains committed to medicalimaging (SCAN 9/28/94).
New AI-Powered Ultrasound Devices May Enhance Efficiency in Women's Imaging
April 19th 2024One of the features on the new Voluson Signature 20 and 18 ultrasound devices reportedly uses automated AI tools to facilitate a 40 percent reduction in the time it takes to perform second trimester exams.
FDA Approves Fluorescence Imaging System for Detecting Residual Breast Cancer
April 18th 2024The combination of the optical imaging agent Lumisight and the fluorescence imaging device Lumicell Direct Visualization System, collectively known as LumiSystem, reportedly offers 84 percent accuracy with real-time detection of residual breast cancer after lumpectomy procedures.
Study of Ofatumumab for Multiple Sclerosis Shows 'Profoundly Suppressed MRI Lesion Activity'
April 17th 2024The use of continuous ofatumumab in patients within three years of a relapsing multiple sclerosis diagnosis led to substantial reductions in associated lesions on brain MRI scans, according to research recently presented at the American Academy of Neurology (AAN) conference.
